Daiichi Sankyo Company, Limited (DSNKY)
Data as of September 10, 2026 · Drug Manufacturers - General
Stockbruh grade: Mixed 3/5 metrics rated Sunny
What does Daiichi Sankyo Company, Limited do?
Daiichi Sankyo 🏢 is a global pharmaceutical company that develops and sells a wide range of products to treat various health conditions. From anti-cancer agents like trastuzumab deruxtecan to skincare products like Minon, they've got you covered. 🌟 Based in Tokyo 🗼, they've been making a positive impact since 1899. 💪🏼💊.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛈️ Weak | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ☀️ Strong | Revenue & earnings trend |
| Earnings | ⛅ Moderate | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $17.56 | Market Cap | — |
| Exchange | Other OTC | | |
Plain-English Analysis
What's it worth?
Returns have been below average recently — worth reviewing valuation carefully before investing. Sign up free to see the full Stockbruh valuation breakdown.
How the business works
Daiichi Sankyo 🏢 is a global pharmaceutical company that develops and sells a wide range of products to treat various health conditions. From anti-cancer agents like trastuzumab deruxtecan to skincare products like Minon, they've got you covered. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Revenue and earnings are trending upward — Daiichi Sankyo Company, Limited appears to be growing. Sign up free for the full growth analysis including year-over-year comparisons and R&D investment data.
What's ahead?
Earnings are mixed. Sign up free for the full earnings picture including EPS history and analyst forecasts.